B4GALT1 - beta-1,4-galactosyltransferase 1 Gene
Also Known as GT1; GTB; CDG2D; GGTB2; B4GAL-T1; beta4Gal-T1
Species: Homo sapiens
About B4GALT1
This gene has 2 transcripts (splice variants), 279 orthologues, 6 paralogues and is associated with 3 phenotypes. Ubiquitous expression in thyroid (RPKM 45.3), gall bladder (RPKM 35.7) and 25 other tissues.
Summary
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either Monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase. [provided by RefSeq, Jul 2008]
B4GALT1 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_001378495.1 | NP_001365424.1 | beta-1,4-galactosyltransferase 1 isoform 2 |
| NM_001378496.1 | NP_001365425.1 | beta-1,4-galactosyltransferase 1 isoform 3 |
| NM_001378497.1 | NP_001365426.1 | beta-1,4-galactosyltransferase 1 isoform 4 |
| NM_001497.4 | NP_001488.2 | beta-1,4-galactosyltransferase 1 isoform 1 |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in lipid metabolic process |
IMP
IMP: Inferred from mutant phenotype
|
34855475 | GOA |
| involved in oligosaccharide biosynthetic process |
IDA
IDA: Inferred from direct assay
|
2120039 | GOA |
| involved in positive regulation of circulating fibrinogen levels |
IMP
IMP: Inferred from mutant phenotype
|
34855475 | GOA |
| involved in protein N-linked glycosylation |
IDA
IDA: Inferred from direct assay
|
16157350 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in Golgi apparatus |
IDA
IDA: Inferred from direct assay
|
7744867 | GOA |
| located in Golgi trans cisterna |
IDA
IDA: Inferred from direct assay
|
6121819 | GOA |
| located in basolateral plasma membrane |
IDA
IDA: Inferred from direct assay
|
3917437 | GOA |
| located in brush border membrane |
IDA
IDA: Inferred from direct assay
|
3917437 | GOA |
| located in desmosome |
IDA
IDA: Inferred from direct assay
|
3917437 | GOA |
| located in external side of plasma membrane |
IDA
IDA: Inferred from direct assay
|
3917437 | GOA |
B4GALT1 Protein Structure
Glyco_transf_7N: N-terminal region of glycosyl transferase group 7 (130 - 263)
Glyco_transf_7C: N-terminal domain of galactosyltransferase (267 - 343)
- 0
- 100
- 200
- 300
- 398 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
beta-1,4-galactosyltransferase 1 |
|
Recombinant B4GALT1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P7628 | B4GALT1 Protein, Human (HEK293, Y285L, His) | P15291-1 (G44-S398, Y285L) | ≥ 95%, as determined by reducing SDS-PAGE. |
B4GALT1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P811132 | B4GALT1 Antibody | WB, IHC-P | Human, Mouse, Rat |
| HY-P89816 | β-1,4-Gal-T1 Antibody (YA9160) | WB, ICC/IF, IF-Tissue, IP, ELISA | human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Congenital Disorder Of Glycosylation, Type Iid |
|
|
| Immunodeficiency 47 |
|
|
| Tibialis Tendinitis |
|
|
| Congenital Disorder Of Glycosylation, Type Iif |
|
|
| Congenital Disorder Of Glycosylation, Type Iia |
|
|
| Fructose Intolerance, Hereditary |
|
|
| Congenital Disorder Of Glycosylation, Type Iib |
|
|
| Congenital Disorder Of Glycosylation, Type Iii |
|
|
| Peters-Plus Syndrome |
|
|
| Congenital Disorder Of Glycosylation, Type In |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | B4GALT1 | VGNC | VGNC:26388 |
| Macaca mulatta | B4GALT1 | VGNC | VGNC:104877 |
| Canis familiaris | B4GALT1 | VGNC | VGNC:38349 |
| Mus musculus | B4GALT1 | MGD | MGI:95705 |
| Felis catus | B4GALT1 | VGNC | VGNC:68980 |
| Rattus norvegicus | B4GALT1 | RGD | RGD:620900 |
| Others | B4GALT1 | NCBI |